UPDATE 1-Bristol immune drug shows strong effect in melanoma study
September 29, 2014 at 04:47 AM EDT
* 32 percent response rate in patients treated with Opdivo
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.